Integrin Α4β7 is an Immunological Marker for HIV Preference in Activated Peripheral and Cervical CD4+ T Cells (VIR8P.1066)

Theresa Chang,Jian Ding,Carley Tasker,Wuyuan Lu,Pierre Lespinasse,Debra Heller

DOI: https://doi.org/10.4049/jimmunol.192.supp.209.2

2014-01-01

Abstract:Abstract CD4+ T cells, the principal target in acute SIV and HIV infection, are crucial for the establishment and dissemination of HIV infection in mucosal tissues. Studies indicate that α4β7 CD4+ T cells are preferentially infected by HIV in vitro and during acute SIV infection. Integrin α4β7 is thought to promote HIV capture by target cells; however, the role of integrin α4β7 in HIV transmission remains controversial. In this study, we characterized immunological profiles of human cervical T cells and examined HIV preference in α4β7+ CD4+ T cells. In vitro all-trans retinoic acid differentiated peripheral CD4+ T cells were included as a comparison. In both peripheral and cervical cells, HIV preferentially infected CD38+ activated cells. Although integrin α4β7 was not the major determinant for HIV preference, the majority of HIV p24+ cells were found in activated CD4+ T cells expressing α4β7. Interestingly, CCR5 was not a marker for HIV preference. The cyclic hexapeptide CWLDVC and monoclonal antibody against integrin α4β7 did not block HIV attachment or gp120 binding to target cells regardless the presence of CD4, indicating that integrin α4β7 did not contribute to facilitating HIV capture by target cells. Our results suggest that integrin α4β7 may play a role in HIV susceptibility but not through promoting HIV binding to target cells.